Literature DB >> 13059636

Gamma globulin; status of availability for prevention of poliomyelitis.

W L HALVERSON, R M DRAKE.   

Abstract

A limited and temporary preventive effect has been noted for gamma globulin used under certain conditions. There is available a supply of gamma globulin which is inadequate to meet the demand with the methods of use indicated in the light of present knowledge. All supplies of gamma globulin have been placed under the responsibility of the Office of Defense Mobilization. Supplies allocated to the state of California are being made available to physicians through their local health departments on the basis of past and current incidence of poliomyelitis for use in protecting persons in household contact with patients with diagnosed cases. The most effective use of California's allocation of this material can be expected to prevent or modify approximately 40 cases on the basis of the past five-year experience (1947-1951). Parents, physicians and health officials must know the facts and cooperate to make the best of a difficult situation.

Entities:  

Keywords:  POLIOMYELITIS/prevention and control; SERUM GLOBULIN

Mesh:

Substances:

Year:  1953        PMID: 13059636      PMCID: PMC1521754     

Source DB:  PubMed          Journal:  Calif Med        ISSN: 0008-1264


  8 in total

1.  Evaluation of Red Cross gamma globulin as a prophylactic agent for poliomyelitis. IV. Final report of results based on clinical diagnoses.

Authors:  W M HAMMON; L L CORIELL; P F WEHRLE; J STOKES
Journal:  J Am Med Assoc       Date:  1953-04-11

2.  Further studies on oral administration of living poliomyelitis virus to human subjects.

Authors:  H KOPROWSKI; G A JERVIS; T W NORTON; D J NELSEN
Journal:  Proc Soc Exp Biol Med       Date:  1953-02

3.  Studies in human subjects on active immunization against poliomyelitis. I. A preliminary report of experiments in progress.

Authors:  J E SALK
Journal:  J Am Med Assoc       Date:  1953-03-28

4.  Evaluation of Red Cross gamma globulin as a prophylactic agent for poliomyelitis. I. Plan of controlled field tests and results of 1951 pilot study in Utah.

Authors:  W M HAMMON; L L CORIELL; J STOKES
Journal:  J Am Med Assoc       Date:  1952-10-25

5.  Evaluation of Red Cross gamma globulin as a prophylactic agent for poliomyelitis. 2. Conduct and early follow-up of 1952 Texas and Iowa-Nebraska studies.

Authors:  W M HAMMON; L L CORIELL; J STOKES
Journal:  J Am Med Assoc       Date:  1952-10-25

6.  Evaluation of Red Cross gamma globulin as a prophylactic agent for poliomyelitis. 3. Preliminary report of results based on clinical diagnosis.

Authors:  W M HAMMON; L L CORIELL; P F WEHRLE; C R KLIMT; J STOKES
Journal:  J Am Med Assoc       Date:  1952-10-25

7.  Distribution of poliomyelitis virus in the epidemic community.

Authors:  T FRANCIS
Journal:  Trans Assoc Am Physicians       Date:  1952

8.  Poliomyelitis in pregnancy.

Authors:  G W ANDERSON; G ANDERSON; A SKAAR; F SANDLER
Journal:  Am J Hyg       Date:  1952-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.